Patent · US Expired

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

US6888022B2 · kind B2 · utility

1Cited by
11References
71Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 20, 2001
Grant dateMay 3, 2005
Priority date
Expiry dateMar 13, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/06078
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.